Astec Lifesciences consolidated net profit declines 38.32% in the March 2017 quarter

Sales rise 12.67% to Rs 88.33 crore

Net profit of Astec Lifesciences declined 38.32% to Rs 3.46 crore in the quarter ended March 2017 as against Rs 5.61 crore during the previous quarter ended March 2016. Sales rose 12.67% to Rs 88.33 crore in the quarter ended March 2017 as against Rs 78.40 crore during the previous quarter ended March 2016.

For the full year,net profit rose 284.71% to Rs 19.12 crore in the year ended March 2017 as against Rs 4.97 crore during the previous year ended March 2016. Sales rose 29.93% to Rs 303.66 crore in the year ended March 2017 as against Rs 233.71 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales88.3378.40 13 303.66233.71 30 OPM %18.5218.57 -20.7113.50 - PBDT14.5816.56 -12 53.0225.97 104 PBT10.1613.41 -24 39.3415.57 153 NP3.465.61 -38 19.124.97 285

Powered by Capital Market - Live News